Physician Assistant · Las Vegas, NV
NPI
1699382465
Since 2020
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4750 W Oakey Blvd Ste 3a
Las Vegas, NV, 89102
Phone (702) 877-5199
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,059
130 services
Medicare patients, 2024
59
Average age 65
Drug cost, 2024
$2.9M
6,109 prescriptions
Company payments, 2025
$1,523
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly Roberts was code 99214 (office e&m - established), 124 times for 58 patients. In total Kelly Roberts billed 130 services in 3 codes, and Medicare paid $9,059.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 124 | 58 | $69.35 | $8,600 |
By year: 2022 $6,329 for 81 services; 2023 $7,423 for 112 services; 2024 $9,059 for 130 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kelly Roberts prescribed most often to Medicare patients was Soliqua 100-33 (Insulin Glargine/Lixisenatide), with 621 prescriptions and refills. In total Kelly Roberts wrote 6,109 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 621 | 784 | 119 | $665K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 493 | 729 | 147 | $85K |
| Metformin Hcl Generic | 322 | 912 | 104 | $3,545 |
| Jardiance Empagliflozin | 322 | 594 | 83 | $358K |
| Ozempic Semaglutide | 320 | 426 | 75 | $410K |
| Atorvastatin Calcium Generic | 305 | 871 | 113 | $2,926 |
| Metformin Hcl Er Metformin Hcl | 286 | 721 | 92 | $2,572 |
| Glipizide Generic | 253 | 669 | 86 | $1,741 |
| Humalog Kwikpen U-100 Insulin Lispro | 240 | 354 | 86 | $65K |
| Levothyroxine Sodium Generic | 217 | 626 | 73 | $1,975 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 212 | 560 | 97 | $24K |
| Mounjaro Tirzepatide | 193 | 234 | 34 | $258K |
| Lisinopril Generic | 152 | 431 | 47 | $1,162 |
| Gabapentin Generic | 138 | 213 | 35 | $2,414 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 127 | 153 | 47 | $31K |
Brand drugs: 3,258 claims; generic drugs: 2,309 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly Roberts $1,523 ($1,523 in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $334.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 8 | $334 |
| Dexcom, Inc. DXCM | 12 | $266 |
| Averitas Pharma Inc. | 3 | $140 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $101 |
| Amgen Inc. AMGN | 5 | $87.43 |
| Abbott Laboratories ABT | 3 | $87.31 |
| Insulet Corporation PODD | 1 | $80.24 |
| Kyowa Kirin, Inc. 4151.T | 2 | $55.86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52.49 |
| Soleno Therapeutics, Inc. SLNO | 2 | $48.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.